Finasteride and Methadone Use and Risk of Advanced Hepatitis C Related Liver Disease
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
We evaluated the association between two medications that alter bioavailable androgen levels, finasteride and methadone, and risk of advanced HCV-related liver disease.
Males have strikingly greater cirrhosis risk across disease etiologies, including hepatitis C virus (HCV) infection.
In a cross-sectional study in HCV+ male veterans, we determined medication use by up to 15-year medical record review, and hepatic pathology by the FibroSURE-ActiTest (F3/F4-F4, advanced vs. F0-F3, mild fibrosis; and A2/A3-A3, advanced vs. A0-A2, mild inflammation). We performed race-adjusted and race-stratified multivariate analyses.
Among 571 HCV+ males, 43 % were White and 57 % African-American. There were non-significant decreased risks with finasteride use (ORadj advanced fibrosis = 0.75, 95 % CI 0.39–1.45 and ORadj advanced inflammation = 0.74, 95 % CI 0.41–1.43). For methadone, there was a non-significant 41 % increased advanced fibrosis risk in Whites and 51 % reduced risk in AA. White male methadone-users had 2.1-fold excess advanced inflammation risk (p = 0.15).
Our preliminary study results suggest finasteride use is not significantly associated with a decreased risk of advanced hepatic fibrosis or inflammation in HCV+ males. The ethnically-divergent results for methadone associated fibrosis risk and finding of potentially increased inflammation risk in White males suggests the need for additional research.
- Finasteride and Methadone Use and Risk of Advanced Hepatitis C Related Liver Disease
Digestive Diseases and Sciences
Volume 57, Issue 11 , pp 3004-3010
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- Sex hormones
- Drug addiction
- Industry Sectors
- Author Affiliations
- 1. Clinical Epidemiology and Outcomes Program, Houston VA Health Services Research and Development Center of Excellence, Michael E. DeBakey Veteran Affairs Medical Center, Houston, TX, USA
- 2. Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA
- 3. Section of Gastroenterology and Hepatology, Michael E. DeBakey Veteran Affairs Medical Center, 2002 Holcombe Blvd. (MS 152), Houston, TX, 77030, USA
- 4. Hepatitis C Clinic, Section of Infectious Diseases, Michael E. DeBakey Veteran Affairs Medical Center, Houston, TX, USA
- 5. Section of Infectious Diseases, Department of Medicine, Baylor College of Medicine, Houston, TX, USA